Zileuton
NDC 31722-044, Zileuton, tablet, film coated, extended release, from Camber Pharmaceuticals, Inc..
- Product NDC
- 31722-044
- Status
- Listed
- Labeler
- Camber Pharmaceuticals, Inc.
- Dosage form
- TABLET, FILM COATED, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA215742
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/31722-044 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ZILEUTON600 mg/1
Pharmacologic classes
5-Lipoxygenase Inhibitor [EPC]; 5-Lipoxygenase Inhibitors [MoA]; Decreased Leukotriene Production [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 31722-044-12 | 31722004412 | 120 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (31722-044-12) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/94313e24-9534-4b6c-b374-c436c4916303NADAC price for package 31722004412
GET /v1/drugs/nadac/31722004412
Use it
Look up 31722-044 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/31722-044 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 31722-044. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.